These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4039567)

  • 1. The renal fractional clearance of platinum antitumour compounds in relation to nephrotoxicity.
    Daley-Yates PT; McBrien DC
    Biochem Pharmacol; 1985 May; 34(9):1423-8. PubMed ID: 4039567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid.
    Daley-Yates PT; McBrien DC
    Biochem Pharmacol; 1982 Jul; 31(13):2243-6. PubMed ID: 6889863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the protective effect of chloride salts on cisplatin nephrotoxicity.
    Daley-Yates PT; McBrien DC
    Biochem Pharmacol; 1985 Jul; 34(13):2363-9. PubMed ID: 4040367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin nephrotoxicity: role of filtration and tubular transport of cisplatin in isolated perfused kidneys.
    Miura K; Goldstein RS; Pasino DA; Hook JB
    Toxicology; 1987 May; 44(2):147-58. PubMed ID: 3564050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats.
    Siddik ZH; Newell DR; Boxall FE; Harrap KR
    Biochem Pharmacol; 1987 Jun; 36(12):1925-32. PubMed ID: 3297068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of cisplatin nephrotoxicity.
    Weiner MW; Jacobs C
    Fed Proc; 1983 Oct; 42(13):2974-8. PubMed ID: 6684595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum.
    Dumas M; de Gislain C; d'Athis P; Chadoint-Noudeau V; Escousse A; Guerrin J; Autissier N
    Cancer Chemother Pharmacol; 1989; 23(1):37-40. PubMed ID: 2909288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue injury and repair in the rat kidney after exposure to cisplatin or carboplatin.
    Nonclercq D; Toubeau G; Laurent G; Tulkens PM; Heuson-Stiennon JA
    Exp Mol Pathol; 1989 Oct; 51(2):123-40. PubMed ID: 2680578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative nephrotoxicity of cisplatin, cis-[Pt(NH3)2(guanosine)2]2+, and the hydrolysis product of cisplatin in the rat.
    Jones MM; Basinger MA; Beaty JA; Holscher MA
    Cancer Chemother Pharmacol; 1991; 29(1):29-32. PubMed ID: 1742846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male Wistar rats.
    Wolfgang GH; Dominick MA; Walsh KM; Hoeschele JD; Pegg DG
    Fundam Appl Toxicol; 1994 Jan; 22(1):73-9. PubMed ID: 8125216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of sodium thiosulfate on subcellular localization of platinum in rat kidney after treatment with cisplatin.
    Uozumi J; Litterst CL
    Cancer Lett; 1986 Sep; 32(3):279-83. PubMed ID: 3768854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platinum agent-induced nephrotoxicity via organic cation transport system].
    Yonezawa A
    Yakugaku Zasshi; 2012; 132(11):1281-5. PubMed ID: 23123720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.
    Yasumasu T; Ueda T; Uozumi J; Mihara Y; Kumazawa J
    Pharmacol Toxicol; 1992 Feb; 70(2):143-7. PubMed ID: 1508841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of organic cation transport inhibitors on cis-diamminedichloroplatinum-induced nephrotoxicity.
    Bird JE; Walser MM; Quebbemann AJ
    J Pharmacol Exp Ther; 1984 Dec; 231(3):752-8. PubMed ID: 6542140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minireview. The nephrotoxicity of cisplatin.
    Goldstein RS; Mayor GH
    Life Sci; 1983 Feb; 32(7):685-90. PubMed ID: 6338333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin nephrotoxicity: insights into mechanism.
    Safirstein R; Winston J; Moel D; Dikman S; Guttenplan J
    Int J Androl; 1987 Feb; 10(1):325-46. PubMed ID: 3583421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular metabolites of cisplatin in the rat kidney.
    Mistry P; Lee C; McBrien DC
    Cancer Chemother Pharmacol; 1989; 24(2):73-9. PubMed ID: 2731314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collecting duct function in cis-platinum nephrotoxicity.
    Wilson DR; Honrath U
    Can J Physiol Pharmacol; 1987 Jun; 65(6):1200-4. PubMed ID: 3621067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and metabolism of cisplatin by rat kidney.
    Safirstein R; Miller P; Guttenplan JB
    Kidney Int; 1984 May; 25(5):753-8. PubMed ID: 6540826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective action of glycine in cisplatin nephrotoxicity.
    Heyman SN; Rosen S; Silva P; Spokes K; Egorin MJ; Epstein FH
    Kidney Int; 1991 Aug; 40(2):273-9. PubMed ID: 1942775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.